No Data
No Data
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
H.C. Wainwright Maintains Artiva Biotherapeutics(ARTV.US) With Buy Rating, Maintains Target Price $20
Analysts Are Bullish on These Healthcare Stocks: Artiva Biotherapeutics, Inc. (ARTV), Corvus Pharmaceuticals (CRVS)
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Express News | Wedbush Reiterates Outperform on Artiva Biotherapeutics, Maintains $18 Price Target
Artiva Biotherapeutics Is Maintained at Overweight by Cantor Fitzgerald